After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Agios Pharmaceuticals Inc is $2.63B. A total of 0.88 million shares were traded on the day, compared to an average of 648.40K shares.
In the most recent transaction, Scadden David sold 200 shares of AGIO for 43.84 per share on Nov 12 ’25. After the transaction, the Director now owns 17,603 company shares. In a previous transaction on Nov 11 ’25, Gheuens Sarah sold 2,454 shares at 43.78 per share. AGIO shares that Chief Medical Officer owns now total 61,727.
Among the insiders who bought shares, SARAH GHEUENS acquired of 2,454 shares on Nov 11 ’25 at a per-share price of $43.78. In another insider transaction, Gheuens Sarah sold 200 shares at $43.81 per share on Oct 30 ’25. Company shares held by the Chief Medical Officer now total 61,727.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, AGIO has a high of $62.45 and a low of $23.42.
As of this writing, AGIO has an earnings estimate of -$1.95 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$1.8 per share and a lower estimate of -$2.09. The company reported an EPS of -$1.74 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $22.04, while its Total Shareholder’s Equity was $1.29B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.00.
